ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Patients With Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00437268
Recruitment Status : Completed
First Posted : February 19, 2007
Last Update Posted : April 20, 2010
Sponsor:
Information provided by:
Eli Lilly and Company

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2009
  Actual Study Completion Date : May 2009
  Certification/Extension First Submitted : April 16, 2010